endocrine-uii-2011.ppt
TRANSCRIPT
![Page 1: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/1.jpg)
1
T. UtoroDepartment of Pathology
Gadjah Mada University School of Medicine
PATHOLOGY ENDOKRINOLOGY
![Page 2: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/2.jpg)
2
PATHOLOGY OF THE
T H Y R O I D
![Page 3: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/3.jpg)
3
T H Y R O I D
• Normally weighs between 20 and 30 g.• Follicle is the functional unit of the thyroid
composed of an epithelium-lined sac filled with colloid stores thyroid hormones in the form of thyroglobulin T4 (thyroxine) and T3 (triiodo-thyronine) regulated by TSH
• Serum T4 and T3 are bound to thyroid-binding globulin (TBG)
![Page 4: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/4.jpg)
4
Homeostasis in the hypothalamus-
pituitary-thyroid axis, and mechanism of action of thyroid
hormones
Cellular effects of thyroid hormones-up-regulation of carbohydrate and
lipid catabolism-Stimulation of protein synthesis in
wide range of cells
Net result:Increased the basal metabolic rate
![Page 5: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/5.jpg)
5
Pathology of thyroid
A. CONGENITAL ANOMALYB. GOITERC. HYPOTHYROIDISMD. HYPERTHYROIDISME. THYROIDITISF. BENIGN TUMORS (ADENOMAS)G. MALIGNANT TUMORS
![Page 6: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/6.jpg)
6
Pathology of thyroid
A. CONGENITAL ANOMALY
1. Thyroglosal duct cyst- is a remnant of the thyroglossal duct- is the most common thyroid anomaly- does not lead to alterations in thyroid function
2. Ectopic thyroid tissue- may be found anywhere along the course of the thyroglossal duct
![Page 7: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/7.jpg)
7
Pathology of thyroid
B. GOITER
A chronic enlargement of thyroid gland
due to other than neoplasm
Synonim: STRUMA
![Page 8: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/8.jpg)
8
Pathology of thyroid
B. GOITER
A.CAUSES
a. Physiologic enlargement
- is not uncommon in puberty and pregnancy b. Iodine deficiency
- occurs in geographic areas where diet is deficient in iodinec. Hashimoto thyroiditis
d. Goitrogens
- foods or drugs that suppress synthesis of thyroid hormonee. Dyshormogenesis
- partial or complete failure of thyroid hormone synthesis; can be caused by various enzyme deficiencies
![Page 9: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/9.jpg)
9
Pathology of thyroid
B. GOITERB.TERMINOLOGY
a. Simple goiter (nontoxic goiter)- is goiter without thyroid hormone dysfunction
b. Toxic goiter- is goiter associated with hyperthyroidism
c. Endemic goiter- goiter occurring with high frequency in iodine-deficient geographic areas
d. Nodular goiter- irregular enlargement of the thyroid nodule formation- nodular colloid goiter: late stage simple goiter, in which goiter is most often nodular (most nodules are hypoplastic and do not take up radioactive iodine “cold” nodule)
![Page 10: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/10.jpg)
10
Non-toxic goiter
Irregular nodules
Marked variation in the size of follicles
![Page 11: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/11.jpg)
11
Nodular (non-toxic) Goiter
The gland is coarsely nodular and contains areas of fibrosis and cystic change.
![Page 12: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/12.jpg)
12
Pathology of thyroid
C. HYPOTHYROIDISMDiminished production of thyorid hormone, leadingto clinical manifestation of thyroid insufficiency.It can be the consequences of three general processes Defective synthesis of thyroid hormone, with
compensatory goitrogenesis (goitrous hypothyroidism)
Inadequate function of thyroid parenchyma (usually as a result of thyroiditis, surgical resection, or radioiodine therapy)
Inadequate secretion of TSH by the pituitary or TRH by the hypothalamus
![Page 13: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/13.jpg)
13
Pathology of thyroid
C. HYPOTHYROIDISM
Dominant clinical manifestation
![Page 14: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/14.jpg)
14
Pathology of thyroid
C. HYPOTHYROIDISM
Laboratory abnormalities1. Decrease serum free T4, increased serum TSH
2. Increase serum cholesterol
3. Classic thyroid test
-T3 resin uptake decreased
- Total T4 decreased
![Page 15: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/15.jpg)
15
Pathology of thyroid
C. HYPOTHYROIDISM
Clinical syndromesHypothyroidism is manifest as Myxedema in
adults or as Cretinism in children
![Page 16: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/16.jpg)
16
Pathology of thyroid: C. HYPOTHYROIDISM:
Myxedema
A. More common in womenB. Etiology:
1. Therapy for hyperthyroidism with surgery, irradiation, or drugs 2. Hashimoto thyroiditis3. Unknown – primary idiopathic myxedema – is a poorly defined form of myxedema : TSH receptor blocking antibodies have been identified.4. Iodine deficiency is the most important cause in non-iodine deficient geographic regions
![Page 17: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/17.jpg)
17
Pathology of thyroid: C. HYPOTHYROIDISM:
MyxedemaC. Clinical charateristics
1. Incidious onset 2. Cold intolerance3. Tendency to gain weight because of a low metabolic rate4. Lowered pitch of voice5. Mental and physical slowness6. Menorrhagia7. Constipation8. Abnormal physical findings:
- puffiness of face, eyelids, and hands- dry skin- hair loss; coarse and brittle hair; scant axillary and pubic hair;
thinning of the lateral aspect of the eyebrows- increase in relaxation phase of deep tendon reflexes.
![Page 18: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/18.jpg)
18
Pathology of thyroid: C. HYPOTHYROIDISM:
CRETINISMA. Etiology:
1. Iodine deficiency 2. Deficiency of enzymes necessary for the synthesis of thyroid hormones3. Maldevelopment of the thyroid gland4. Failure of the fetal thyroid to descend from its origin at the base of the tongue 5. Trans placental transfer fo antithyroid antibodies from a mother with autoimmune thyroid disease
B. Characteristics:1. Severe mental retardation2. Impairment of physical growth with retarded bone development and dwarfism3. Large tongue4. Protuberant abdomen
![Page 19: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/19.jpg)
19
Pathology of thyroid
HYPERTHYROIDISM (THYROTOXICOSIS)
A. Clinical Features
1. Restlessness, irritability, fatigability2. Tremor3. Heat intolerance; sweating; warm, moist skin (especially palms)4. Tachycardia, often with arrythmia and palpitation, sometimes with high-output cardiac failure5. Muscle wasting and weight loss despite increase appetite6. Fine hair7. Diarrhea8. Menstrual abnormalities, commonly amenorrhoea or oligomen.9. Greatly increased free T4 and reduced TSH ------ and less commonly employed are increased total T4&T3, and resin uptake
![Page 20: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/20.jpg)
20
Graves disease, hyperthyroidism
Exophthalmos
Thyroid mass
![Page 21: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/21.jpg)
21
Major clinical manifestations
of Graves disease
![Page 22: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/22.jpg)
22
Pathology of thyroid
HYPERTHYROIDISM (THYROTOXICOSIS)
B. Graves DiseaseGeneral Charcteristics
1. Hyperthyroidism caused by diffuse toxic goiter2. Associated with striking exophthalmos autoimmune?3. More in women4. incidence increased in HLA-DR3 and HLA-B8 positive individual
Mechanism
1. Thyroid-stimulating-immunoglobulin (TSI) reacts with TSH receptors stimulates thyroid hormone production2. Thyroid-growth-immunoglobulin (TGI) stimulates glandular hyperplasia and enlargement 3. Antimicrosomal and other autoantibodies are characteristic
![Page 23: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/23.jpg)
23
Pathology of thyroid
HYPERTHYROIDISM (THYROTOXICOSIS)
B. Other causes of hyperthyroidism
1. Plummer Disease- the combination of hyperthyroidism, nodular goiter, and absence of
exophthalmos- the “hot” nodules can be adenomas or non-neoplastic areas of nodular hyperplasia
2. Pituitary hyperfunction- can cause excess production of TSH and secondary hyperthyroidism
3. Struma ovarii- ovarian teratoma made up of thyroid tissue, can be hyperfunctional
4. Exogenous administration of thyroid hormone
![Page 24: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/24.jpg)
24
Graves Disease
Diffusely hyperplastic thyroid with follicle are lined by tall, columnar epithelium, and scalloped (“moth eaten”) appearance of
the edge of the colloid.
![Page 25: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/25.jpg)
25
Graves disease, hyperthyroidism
The follicles are lined by hyperplastic, tall columnar cells
![Page 26: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/26.jpg)
26
Immune mechanism of Graves Disease and Hashimoto Thyroiditis
![Page 27: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/27.jpg)
27
Pathology of thyroid
E. THYROIDITIS
Inflammation of the thyroid gland(encompasses a heterogenous group of inflammatory disorders of the
thyroid gland, including those that are caused by autoimmune
mechanisms and infectious agents)
A. Acute suppurative thyroiditis: a bacterial infection,
usually occurs in young children or debilitated patients. It is rare
B. Subacute granulomatous thyroiditis (De Quervain thyroiditis)
C. Chronic thyroiditis (Hashimoto thyroiditis, Struma lymphomatosa, autoimmune thyroiditis)
D. Riedel’s struma (Riedel’s disease)
![Page 28: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/28.jpg)
28
Subacute/De Quervain/granulomatous Thyroiditis
• Is characterized by focal destruction of thyroid tissue and granulomatous inflammation
• Etiology: variety of viral infections such as mumps or coxsackie virus
• Follows a limited course several weeks of duration consisting of flu-like illness along with pain and tenderness of the thyroid, sometimes with transient hyperthyroidism
• More common in women
![Page 29: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/29.jpg)
29
Subacute/De Quervain/granulomatousThyroiditis
The release of colloid into the interstitial tissue has elicited a prominent granulomatous reaction, with numerous foreign body giant cells
![Page 30: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/30.jpg)
30
Subacute/De Quervain/granulomatous Thyroiditis
The parenchyma contains chronic inflammatory infiltrate with a multinucleate giant cells and colloid folicles
![Page 31: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/31.jpg)
31
Chronic autoimmune (Hashimoto) thyroiditis
• Autoimmune disorder that occur more often in women• Common cause of hypothyroidism, may occasionaly
have an early transient hyperthyroid phase• Characterized histologically by massive infiltrates of
lymphocytes with germinal center formation, thyroid follicles are atrophic, and Hurthle cells are prominent
• Associated with various antibodies (antithyroglobulin, antithyroid peroxidase, anti TSH-receptor, anti-iodine receptor antobodies)
• May be associated with other autoimmune disorders: pernicious anemia, DM, Sjogren syndrome the incidence is increased in HLA-DR5 and HLA-B5 positive
![Page 32: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/32.jpg)
32
Chronic autoimmune (Hashimoto) thyroiditis
The thyroid gland is symmetrically enlarged and coarsely nodular.Coronal section irregular nodules and an intact capsule
![Page 33: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/33.jpg)
33
Chronic autoimmune (Hashimoto) thyroiditis
Atrophic thyroid follicles with conspicuous chronic inflammatory infiltrate(the inflammatory cells form prominent lymphoid follicles with germinal centers)
![Page 34: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/34.jpg)
34
Hashimoto Thyroiditis
Dense lymphocytic infiltrates with germinal centersResidual thyroid follicle lined by Hurthle cells are also seen
![Page 35: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/35.jpg)
35
Riedel thyroiditis
• Characterized by thyroid replacement of fibrous tissue
• Etiology is unknown, does not appear to be related to other thyroiditis
• Also involves extra thyroidal soft tissue of the neck, often associated with fibrosis in other location (retroperitoneum, mediastinum, orbit)
• May clinically mimick carcinoma
![Page 36: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/36.jpg)
36
Riedel thyroiditis
The thyroid parenchyma is largely replaced by dense, hyalinized fibrous tissue and a chronic inflammatory infiltrate
![Page 37: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/37.jpg)
37
Pathology of thyroid
F. BENIGN TUMORS (ADENOMAS)
• Are most often solitary• Present clinically as nodules• Can occur in a variety of histologic
pattern (follicular, Hurthle cell)• Are most often nonfunctional but can
occasionally cause hyperthyroidism• Female:male is 7:1
![Page 38: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/38.jpg)
38
FOLLICULAR ADENOMA
• Embryonal adenoma
• Fetal adenoma
• Simple adenoma
• Colloid adenoma
• Hurthel cell adenoma
• Atypical adenoma
![Page 39: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/39.jpg)
39
Follicular adenoma
Embryonal adenoma
The tumor features a trabecular pattern with poorly formed follicles that contain little if any colloid
![Page 40: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/40.jpg)
40
Follicular Adenoma
COLLOID ADENOMAThe cut surface of an encapsulated mass reveals:
Hemorrhage
Fibrosis
Cystic change
![Page 41: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/41.jpg)
41
Follicular Adenoma
A solitary, well-circumscribed nodule is seen.
Cystic
![Page 42: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/42.jpg)
42
Follicular Adenoma
Well-differentiated follicles resembling normal thyroid parenchyma.
![Page 43: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/43.jpg)
43
Follicular adenoma
FETAL ADENOMA
Regular pattern of small follicles
![Page 44: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/44.jpg)
44
Follicular adenoma
Hurthle cell Adenoma
Cells with abundant eosinophilic cytoplasm and small regular nuclei.
![Page 45: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/45.jpg)
45
Pathology of thyroid
G. MALIGNANT TUMORS
• Papillary Carcinoma• Follicular Carcinoma• Medullary Carcinoma• Anaplastic Carcinoma
![Page 46: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/46.jpg)
46
G. MALIGNANT TUMORS
Papillary Thyroid Carcinoma (PTC)
• Is the most common thyroid cancer (90%)• Most frequent between ages 20 – 50 years• Female:male is 3:1• Papillary growth pattern with ground glass nuclei• Better prognosis than other forms of thyroid cancer ,
even when adjacent lymph nodes is involved• Can be long-term consequence of prior radiotherapy to
the neck• Typically invades lymphatics and spreads to regional
lymph nodes
![Page 47: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/47.jpg)
47
G. MALIGNANT TUMORS
Papillary Thyroid Carcinoma (PTC)
Pathogenesis:• Iodine excess
Animal exp., in endemic goiter region addition of iodine increase incidence
• Radiation
Radiation therapy, and radioactive ray• Genetic factors
First degree relatives of persons with tumor: 4-10 fold higher risk
• Somatic mutation
Somatic rearrangement of RET protooncogene in chromosome 10 (10q11.2)
![Page 48: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/48.jpg)
48
G. MALIGNANT TUMORS
Papillary Thyroid Carcinoma (PTC)
Macroscopic appearance with grossly discernible papillary structure
FNAB - BAJAH
![Page 49: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/49.jpg)
49
G. MALIGNANT TUMORS
Papillary Thyroid
Carcinoma (PTC)
Cut surface diplays a circumscribed pale tan mass with foci of
cystic change
![Page 50: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/50.jpg)
50
G. MALIGNANT TUMORS
Papillary Thyroid Carcinoma (PTC)
Well-formed papillae “Orphan Annie eye”, or ground-glass nuclei, or empty appearing nuclei
![Page 51: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/51.jpg)
51
G. MALIGNANT TUMORS
Papillary Thyroid Carcinoma (PTC) the most common thyroid cancer
Brancing papillae are lined by neoplastic columnar epithelium with clear nuclei. A calcospherite (psammoma body) is evident..
![Page 52: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/52.jpg)
52
G. MALIGNANT TUMORS
Follicular Thyroid Carcinoma (FTC)
• FTC ia defined as a malignant neoplasm that is purely follicular and does not contain papillary or any other elements
• Mostly are detected as a palpable nodule or enlarged thyroid, or as advanced form as bone (pathological fracture), or lung metastasis
• Poorer prognosis than PTC• Differs from PTC in that metastses are blood
borne rather than lymphatic, directed principally to the bones of shoulder and pelvic girdles, sternum, and skull
![Page 53: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/53.jpg)
53
G. MALIGNANT TUMORS
Follicular Thyroid Carcinoma FTC)
Cut surface of follicular carcinoma with the substantial replacement
of the lobe of the thyroid.
The tumor has a light-tan appearance and contains small foci
of hemorrage
![Page 54: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/54.jpg)
54
G. MALIGNANT TUMORS
Follicular Thyroid Carcinoma (FTC)
Glandular lumen contains recognizable colloid
![Page 55: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/55.jpg)
55
G. MALIGNANT TUMORS
Follicular Thyroid Carcinoma (FTC)
Capsular integrity in follicular neoplasm is critical in distinguishing follicular adenoma from carcinoma.Follicular adenoma: capsule is usually thin, occasionally more prominent; no capsular invasion is seen (arrows).Follicular carcinoma: capsular invasion (arrows)
ADENOMA CARCINOMA
![Page 56: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/56.jpg)
56
G. MALIGNANT TUMORS
Follicular Thyroid Carcinoma (FTC)
A microfollicular tumor has invaded veins in the thyroid parenchyma.
![Page 57: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/57.jpg)
57
G. MALIGNANT TUMORS
Medullary Thyroid Carcinoma (MTC)
• MTC is distinguished by its secretion of the calcium-lowering hormone (calcitonin)
• Reprsents no more than 5% of all thyroid cancers• 80% are sporadic form: RET protooncogene
mutation are detected in 25-70% of cases• 20% are familial form: afflicted by MEN type 2
includes phaeochromocytoma and parathyroid hyparplasia, adenoma
• The mean age: 50 years (familial case 20 years)
![Page 58: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/58.jpg)
58
G. MALIGNANT TUMORS
Medullary Thyroid Carcinoma (MTC)
• Tends to arise in superior portion (the region that are richest in C cells--parafollicular)
• Often multicentric and bilateral (MEN setting)• Conspicuous feature: the presence of stromal
amyloid, representing the disposition of calcitonin• The preccursor of the familial form MTC is C cell
hyperplasia• Tumor markers: Calcitonin, CEA, Chromogranin
![Page 59: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/59.jpg)
59
G. MALIGNANT TUMORS: Medullary Thyroid Carcinoma (MTC)
Clinical Features
• Symptoms related to endocrine secretion: carcinoid syndrome (calcitonin), Cushing syndrome (ACTH)
• Watery diarhea in 1/3 cases, caused by secretion of vasoactive intestinal peptide, pros-taglandin, and several kinins
• Familial MTC: hypertension, episodic hypertension, symptoms attributable to the secretion of catechol-amines and phaeochromocytoma
• Therapy: thyroidectomy local recurrencies 1/3 • 5-year survival rate is 75%
![Page 60: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/60.jpg)
60
G. MALIGNANT TUMORS:
Medullary Carcinoma
Solid pattern of growth and do not have connective tissue capsule.
Coronal section total (bilateral) involvement by a firm, pale tumor.
![Page 61: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/61.jpg)
61
G. MALIGNANT TUMORS:
Medullary Thyroid Carcinoma
Nest of polygonal cells embedded in a collagenous framework.
![Page 62: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/62.jpg)
62
G. MALIGNANT TUMORS:
Medullary Thyroid Carcinoma
Amyloid: Congo red staining polarized light microscope pale green birefringent
![Page 63: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/63.jpg)
63
G. MALIGNANT TUMORS:
Medullary Carcinoma
Typically contain amyloid, visible here as homogenous extracellular material, derived from calcitonin molecules secreted by the neoplastic cells
![Page 64: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/64.jpg)
64
G. MALIGNANT TUMORS:
Anaplastic (Undifferentiated) Carcinoma of the Thyroid
• Usually fatal, principally afflict women (4:1) over the age of 60 years
• Constitutes 10% of thyroid cancers• It seems likely that the anaplastic carcinoma
represent the transformation of a benign or lower grade thyroid neoplasm into poorly differentiated and highly aggressive cancer
• Mutation of p53 is common• 5-year survival rate less than 10%
![Page 65: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/65.jpg)
65
G. MALIGNANT TUMORS:
Anaplastic Carcinoma of the Thyroid
The tumor in traverse section partially surround the trachea and extend into the adjecent soft tissue.
![Page 66: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/66.jpg)
66
G. MALIGNANT TUMORS:
Anaplastic Carcinoma
The tumor is composed of bizarre spindle and giant cells with numerous mitoses
![Page 67: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/67.jpg)
67
G. MALIGNANT TUMORS:
Lymphoma of the thyroid
• Are largely B-cell tumors• Accounts for 2% of all thyroid cancers• Most if not all cases arise in the setting of chronic
thyroiditis• More in women (4:1), the mean age is older than
man• Macros: large, soft, tannish masses of thyroid,
usually extending beyond the confines of gland• Micros: same spectrum as other sites, mostly
diffuse large cell pattern
![Page 68: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/68.jpg)
PANKREAS ENDOKRIN
• Diabetes mellitus
• Tumor endokrin (islet cell tumors)
![Page 69: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/69.jpg)
Secretory Products of Islet Cells and Their Physiologic Actions
Cell Secretory Product
Mol. Wt.
Physiological Action
Alpha Glucagon 3500 Catabolic, stimulates glycogenolysis & gluconeogenesis, raises blood glucose
Beta Insulin 6000 Anabolic, stimulates glycogenesis, lipogenesis, protein synthesis, lowers blood glucose. Inhibits secretion of alpha, beta, D1, acinar cells
DeltaD
Somatostatin 1600
DeltaD1
Vasoactive Intestinal Polypeptide (VIP)
3800 Same as glucagon, regulates tone & GE tract motility, activates cAMP of intestinal epithelium
PP Human pancreatic polypeptide (ppp)
4300 Stimulates gastric enzyme secretion, inhibits intestinal motility & bile secretion
EC Serotonin, substance P (motilin)
176 Induce vasodilatation, increases vascular permeability, stimulates motility of gastric muscle and tone of lower esophageal sphincter
![Page 70: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/70.jpg)
NORMAL PANCREAS
![Page 71: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/71.jpg)
Staining of immunoperoxidase technique for insulin insulin containing cells are darkly stained
![Page 72: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/72.jpg)
DIABETESKlasifikasi & gambaran umum1. DM Tipe 1
2. DM Tipe 2
3. Maturity-onset DM of the young (MODY)
4. DM sekunder
a. Penyakit pankreas
(1) Hemokromatosis Herediter (bronze
diabetes)
(2) Pankreatitis
(3) Ca pankreas
b. Penyakit endokrin lain
c. Kehamilan
Patofisiologi
![Page 73: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/73.jpg)
DIABETES Tipe 1Insulin-dependent DM (IDDM), juvenile or
ketosis-prone DM• Mulai lebih dini, biasanya sebelum umur 30 th• Lebih jarang dari pada tipe 2• Karena kegagalan sintesis insulin oleh sel beta pulau
Langerhans pankreas• Etiologi: predisposisi genetik dengan komplikasi proses
inflamasi autoimun dan dipicu oleh infeks virus atau faktor lingkungan
• Riwayat keluarga << tipe 2• Insiden sangat meningkat pada individu dengan mutasi
titik pada gena HLA-DQ, dan sangat tinggi pada individu dengan HLA-DR3 & HLA-DR4 positif
![Page 74: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/74.jpg)
![Page 75: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/75.jpg)
DIABETES Tipe 1
• Kalau tidak diberikan insulin akan terjadi Intoleransi karbohidrat dengan hiperglikemia poliuri, polidipsi, penurunan berat badan / nafsu makan naik, ketoasidosis, koma kematian
• Ketoasidosis akibat dari meningkatnya katabolisme lemak keton bodies (yang tidak terbatas pada ketoasidosis tetapi juga pada kelaparan – jauh lebih ringan)
![Page 76: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/76.jpg)
DIABETES Tipe 2
• Jauh lebih banyak dari pada tipe 1• Mulai pada umur pertengahan (paling sering)• Mekanisme:
1. peningkatan resistensi terhadap insulin akibat dari
penurunan reseptor insulin di membran atau
2. karena disfungsi pos-reseptor; atau
3. dapat berhubungan dengan terganggunya proses
perubahan proinsulin insulin
4. Penurunan sensing glukosa oleh sel beta
5. Gangguan fungsi protein pembawa intraselular
![Page 77: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/77.jpg)
DIABETES Tipe 2
Faktor etiologik:• Riwayat keluarga positive lebih sering dari pada tipe 1• Paling sering dihubungkan dengan obesitas sedang
sampai berat
Gejala / karakteristik:• Kadar insulin plasma normal atau meningkat• Intoleransi karbohidrat ringan diet dan OAD, insulin
biasanya tidak diperlukan• Ketoasidosis tidak biasa kecuali pada keadaan stress
tertentu misalnya pada infeksi dan operasi
![Page 78: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/78.jpg)
![Page 79: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/79.jpg)
Maturity-onset diabetes mellitus of the young
MODY
• Sindroma autosom dominan ditandai dengan hiperglikemia ringan dan hiposekresi insulin, tanpa hilangnya sel beta
• Onset lebih dini dari pada tipe 2• Disebabkan karena keaneka-ragaman
kelompok dari defek gena tunggal pada
![Page 80: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/80.jpg)
DM Sekunder
• Muncul sebagai manifestasi sekunder dari pankreas dan penyakit endokrin yang lain dan kehamilan
1. Penyakit pankreas
2. Penyakit endokrin lain
3. Kehamilan
![Page 81: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/81.jpg)
DM Sekunder
1. Penyakit pankreas
1.Hemokromatosis herediter (bronze diabetes)• Ditandai oleh absorpsi besi berlebihan dan deposisi
hemosiderin parenkimal, dengan fibrosis reaktif pada berbagai organ terutama pankreas, hati, jantung
2.Pankreatitis• Radang akut ditandai hiperglikemi; radang kronis
berakibat destruksi pulau Langerhans DM sekunder
3.Ca pankreas• Diabetes bisa sebagai gejala
![Page 82: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/82.jpg)
DM Sekunder
2. Penyakit endokrin lain
1.Cushing Syndrome• Berakibat hiperglikemia dan peningkatan
glukoneogenesis dan gangguan pemakaian glukosa perifer
2.Akromegali• Berakibat hiperglikemia karena efek laksana-anti insulin
dari GH (hormon pertumbuhan)3.Hipersekresi glukagon• Menyebabkan glikogenolisis – karena tumor sel alfa
(glukagonoma)4.Kelainan endokrin lain• Feokromositoma & hipertroidisme kadang dihubungkan
dengan hiperglikemia
![Page 83: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/83.jpg)
Patofisiologi DM1.Pulau-pulau Langerhansa. DM tipe 1• Pulau-pulau kecil dan sel-sel beta sangat berkurang atau
hilang• Adanya radang dengan sebukan limfosit padat sangat
spesifik pada tingkat awal b. DM tipe 2• Fibrosis dan hialinisasi fokal pada pulau2 (karena
deposit amilin) cukup karakteristik tapi tidak spesifik• Depoisisi amylin (islet amyloid polypeptide, IAPP) dalam
pulau-pulau karakteristik untuk DM tipe 2 mengganggu perubahan proinsulin ke insulin atau sensing insulin oleh sel beta
![Page 84: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/84.jpg)
Amyloid of a pancreatic islet
![Page 85: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/85.jpg)
Patofisiologi DM
2.Ginjal• Manifestasi awal pada ginjal yang sering: penebalan
membrana basalis• Akibat umum: glomerulosklerosis difus, fokal (penyakit
Kimmelstiel-Wilson), lesi arteriolar, lesi eksudatif• Hiperglikemi lama tanpa terapi lesi Armani-Ebstein
(deposisi glikogen tubular)• Pielonefritis: komplikasi yang sering, kadang bersama
nekrosis papilar renal
![Page 86: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/86.jpg)
Hyaline arteriolosclerosis of afferent arteriolae of kidney
![Page 87: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/87.jpg)
Nodular glomerulosclerosis
![Page 88: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/88.jpg)
Nephrosclerosis in long standing diabetes
![Page 89: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/89.jpg)
Patofisiologi DM
3. Sistem kardiovaskular• Insiden aterosklerosis sangat meningkat, pada usia
lebih muda, dan meningkat tinggi pada wanita pre & post menopausal
• Komplikasi: infark miokard dan insufisiensi vaskular perifer (sering dengan gangren tungkai bawah)
• Penebalan membrana basalis kapilar organ multipel dan diperkirakan karenaglikosilasi protein membran non-enzimatik
![Page 90: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/90.jpg)
Patofisiologi DM4.Mata• Paling sering: katarak• Retinopati proliferatif (eksudat retina, edema,
hemoragi, mikroaneurisma vasa kecil)
5.Sistem syaraf• Perubahan: neuropati perifer, otak, dan medula
spinalis
6.Hati• Perlemakan hati
7.Kulit:• Xantoma• Furunkel dan abses, infeksi jamur
![Page 91: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/91.jpg)
![Page 92: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/92.jpg)
Diabetic retinopathy
![Page 93: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/93.jpg)
TYPE I VERSUS TYPE II DM
![Page 94: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/94.jpg)
TUMOR ENDOKRIN PANKREAS
1.Insulinoma (tumor sel beta)• Paling banyak, bisa jinak atau ganas• Sekresi insulin berlebihan (mengandung C-peptide)
harus dibedakan dengan insulin eksogen (terapi – tidak mengandung C-peptide)
• Trias Whipple:• Hiperinsinemia & hipoglikemia episodik• Disfungsi CNS sementara karena hipoglikemia (confuse,
anxiety, stupor, convulsion, coma)• Segera menjadi normal kembali dengan pemberian
glukose
![Page 95: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/95.jpg)
Insulinoma : ribbon or brown stained cells resembling those of the normal islet of Langerhans
![Page 96: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/96.jpg)
TUMOR ENDOKRIN PANKREAS
2.Gastrinoma • Tumor ganas, bisa ekstra pankreas• Sekresi gastrin• Berhubungan dengan sindroma Zolinger-Ellison
3.Glukagonoma (tumor sel alfa)• Jarang, berakibat DM sekunder dan lesi kulit khas:
eritema migratori nekrolitik
4.Vipoma• Jarang, sekresi vasoactive intestinal peptide (VIP)• Berhubungan dengan sindroma WDHA (Watery
Diarrhea Hypokalemia and Achlorhydria) = sindroma Verner-Morrison = kolera pankreatik
![Page 97: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/97.jpg)
Multiple Endocrine Neoplasia (MEN)
• Kelompok sindroma autosomal dominan dengan hiperfungsi lebih dari satu organ endokrin
• Kemungkinan berhubungan dengan hiperplasia atau tumor
• Jenis:
1. MEN I (sindroma Werner)
2. MEN IIa (sindroma Sipple)
3. MEN IIb (MEN III)
![Page 98: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/98.jpg)
MEN I (WERMER SYNDROME)
• Termasuk hyperplasia tumor hipofisis, paratiroid, atau pankreas endokrin (3Ps)
• Bisa tambah hyperplasia atau tumor tiroid atau adrenal cortex
• Komponen pankreatiknya dapat bermanifestasi sebagai sindroma Zollinger-Ellison, hiperinsulinisme, atau cholera pankreatik
• Berhubungan dengan mutasio pada gena MEN I
![Page 99: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/99.jpg)
MEN IIa (Sipple syndrome)
• Termasuk pheochromocytoma, medullary
carcinoma tiroid, dan hiperparatiroidisme karena hiperplasia atau tumor
• Berhubungan dengan mutasi onkogena ret
![Page 100: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/100.jpg)
MEN IIb / III
• Includes pheochromocytoma, medullary carcinoma, and multiple mucocutaneous neuroma or ganglioneuroma. In contrast to MEN IIa, does not induce hyperparathy-roidism.
- is linked to different mutations in the ret
oncogene than is MEN IIa
![Page 101: ENDOCRINE-UII-2011.ppt](https://reader033.vdocuments.net/reader033/viewer/2022051415/55cf9373550346f57b9d8b52/html5/thumbnails/101.jpg)